TABLE 3.

Results of IgM Dipstick assay, IFA, MAT, and dot-ELISA performed on specimens of clinically diagnosed leptospirosis patients (first set)^a

Patient no.	Length of fever before hospital arrival (day)	IgM resultb		IFA result	MAT titer(s) (serovar[s])	Result of antigen detection in urine by dot-ELISA performed on sample collected at day:
		1st	2nd			1	2	3	7	14
1	3	−	+	+	1:100 (copenhageni and saigon)	+	−	0	0	0
2	3	−	+	+	1:400 (bratislava)	+	+	0	0	+
3	3	−	+	+	1:100 (sejroe)	+	+	0	+	0
4	6	−	+	+	1:100 (bangkok, copenhageni, and saigon)	+	+	0	0	0
5	3	−	+	+	1:200 (sejroe)	+	0	0	0	−
6	3	+	0	+	1:100 (bratislava)	−	+	+	0	0
7	4	+	0	+	1:100 (bangkok and sejroe), 1:200 (bratislava and icterohaemorrhagiae), 1:400 (rachmati)	+	+	0	0	+
8	7	+	0	+	1:100 (bratislava), 1:200 (saigon)	+	+	+	0	0
9	8	+	0	+	1:100 (bangkok and sejroe), 1:200 (bratislava)	+	+	0	0	0
10	4	+	0	+	1:100 (bangkok and sejroe), 1:200 (bratislava)	+	−	0	0	0
11	4	+	0	+	1:200 (saigon), 1:400 (pyrogenes)	−	−	+	+	+
12	4	+	0	+	1:100 (pyrogenes and sejroe), 1:200 (autumnalis [Akiyami A] and bratislava)	+	−	0	0	−
13	3	+	0	+	1:100 (bangkok and copenhageni), 1:200 (sejroe), 1:400 (rachmati), 1:800 (saigon)	+	+	0	0	0
14	3	+	0	+	1:100 (saigon), 1:200 (autumnalis [Akiyami A]), 1:400 (copenhageni), 1:800 (bangkok and bratislava)	+	−	0	+	0
15	2	+	0	+	1:100 (bangkok, sejroe, and rachmati), 1:200 (bratislava)	−	+	0	−	0
16	5	+	0	+	1:200 (saigon)	+	+	+	+	+
17	3	+	0	+	1:100 (wolffi)	+	+	0	0	0
18	3	+	0	+	1:100 (wolffi), 1:800 (bratislava)	−	+	+	0	0
19	1	+	0	+	−	+	+	0	0	+
20	4	+	0	+	−	+	+	0	0	0
21	3	+	0	+	−	−	−	−	0	+
22	4	+	0	−	0	+	+	0	0	0
23	4	+	0	−	0	+	−	0	−	0
24	3	+	0	−	0	−	+	+	+	+
25	2	+	0	−	0	+	+	+	+	0
26	2	+	0	−	0	+	+	0	0	0
27	3	+	0	−	0	−	+	+	+	+
28	2	+	0	−	0	−	0	+	0	0
29	2	+	0	−	0	+	+	0	0	0
30	3	+	0	−	0	+	+	0	0	0
31	2	−	−	0	0	+	−	0	0	−
32	3	−	−	0	0	+	+	0	−	0
33	5	−	−	0	0	+	+	+	0	0
34	3	−	−	0	0	+	0	0	0	0
35	3	−	−	0	0	−	0	+	−	−
36	2	−	−	0	0	+	−	−	0	−
No. positive/total no. tested		25/36	5/11	21/30	18/21	27/36	23/32	11/13	7/11	8/12
% Positivity		69.4	45.5	70.0	85.7	75.0	71.9	84.6	63.6	66.7
Cumulative positivity [no. (%)]		25 (69.4)	30 (83.3)	21 (70.0)	18 (85.7)	27 (75)	32 (88.9)	35 (97.2)	35 (97.2)	36 (100)

^a+, positive; −, negative; 0, no sample.

^b1st, serum sample collected on the first day of hospitalization; 2nd, serum samples collected on day 5 or 6 of hospitalization.